PMC:7105881 / 20978-21267
Annnotations
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T236","span":{"begin":118,"end":123},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":" vaccines maintain strong safety profile; however, the immunogenicity of these vaccines is usually lower than that of virus- or viral vector-based vaccines, often requiring optimization of sequences, components, or immunization routes, inclusion of appropriate adjuvants, or application of"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T86","span":{"begin":261,"end":270},"obj":"Chemical"},{"id":"T87","span":{"begin":275,"end":286},"obj":"Chemical"}],"attributes":[{"id":"A86","pred":"chebi_id","subj":"T86","obj":"http://purl.obolibrary.org/obo/CHEBI_60809"},{"id":"A87","pred":"chebi_id","subj":"T87","obj":"http://purl.obolibrary.org/obo/CHEBI_33232"}],"text":" vaccines maintain strong safety profile; however, the immunogenicity of these vaccines is usually lower than that of virus- or viral vector-based vaccines, often requiring optimization of sequences, components, or immunization routes, inclusion of appropriate adjuvants, or application of"}
LitCovid-PMC-OGER-BB
{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T404","span":{"begin":55,"end":69},"obj":"BV_15"},{"id":"T405","span":{"begin":118,"end":123},"obj":"NCBITaxon:10239"},{"id":"T406","span":{"begin":128,"end":133},"obj":"NCBITaxon:10239"},{"id":"T407","span":{"begin":134,"end":140},"obj":"SO:0000440"},{"id":"T408","span":{"begin":261,"end":270},"obj":"CHEBI:60809;CHEBI:60809"},{"id":"T59089","span":{"begin":55,"end":69},"obj":"BV_15"},{"id":"T76777","span":{"begin":118,"end":123},"obj":"NCBITaxon:10239"},{"id":"T8584","span":{"begin":128,"end":133},"obj":"NCBITaxon:10239"},{"id":"T89721","span":{"begin":134,"end":140},"obj":"SO:0000440"},{"id":"T49013","span":{"begin":261,"end":270},"obj":"CHEBI:60809;CHEBI:60809"}],"text":" vaccines maintain strong safety profile; however, the immunogenicity of these vaccines is usually lower than that of virus- or viral vector-based vaccines, often requiring optimization of sequences, components, or immunization routes, inclusion of appropriate adjuvants, or application of"}